To evaluate PD-L1 status in patients with stage III melanoma, Madore et al. [56] assessed its expression by IHC in 52 AJCC stage III melanoma lymph node specimens and compared these results with specimen-matched comprehensive clinicopathologic, genomic, and transcriptomic data. The gene discussed is CD274; the disease is melanoma.